Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-003575-11Phase 3Completed
Phase 3, randomised, double-blind trial in Hypoandrogenism (TD) and sex hormone disorder comparing Colecalciferol 20,000 IU weekly with Placebo (2 arms). Primary endpoint: Change in total testosterone. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-003575-11.